Cooperative Agreement FA86502526L12
Award Date
3/18/25
Completion Date
3/18/27
Dollars Obligated
$1.5M
Funding Federal Agency
Air Force
Awarding Federal Agency
Air Force Research Laboratory
Federal Grant Program
12.800
Assistance Type
Cooperative Agreement
Place of Performance
United States
Similar Awards
This Cooperative Agreement award from the Department of the Air Force's Defense Research Sciences Program (CFDA 12.800) provides $167,000.00 to the University of Maryland, Baltimore (UMB) to study the "Effects of Long-Range Aeromedical Evacuation on Military Relevant Complex Injuries". The performance period for this award is from July 26, 2023 to October 26, 2024. UMB, as the prime awardee, will leverage its expertise and facilities in medical and biomedical research to conduct...
This Cooperative Agreement award from the U.S. Air Force under CFDA 12.800 - Air Force Defense Research Sciences Program provides $730,466.18 in funding to the University of Maryland, Baltimore (UMB) for the "AUSTERE ECMO VALIDATION" project. The award period runs from February 2, 2024 to February 2, 2026.
The project is focused on conducting research and validation activities related to extracorporeal membrane oxygenation (ECMO) technology in austere environments. UMB, a major...
This Cooperative Agreement award from the Department of the Air Force (CFDA 12.800 - Air Force Defense Research Sciences Program) provides $479,000.00 to the University of Maryland, Baltimore to conduct research on "MEASURING DYSAUTONOMIA FOR THE RAPID DETERMINATION AND PROGRESSION OF TBI". The 3-year project, beginning on March 14, 2025, will focus on developing methods to rapidly assess and monitor traumatic brain injury (TBI) through the measurement of dysautonomia, or abnormal...
This federal Cooperative Agreement award for $501,000.00, titled "DEFEROXAMINE AS A RESUSCITATIVE ADJUVANT TO MITIGATE DAMAGE CAUSED BY COMBINED TRAUMATIC BRAIN INJURY", was issued by the Department of the Air Force under the Air Force Defense Research Sciences Program (CFDA 12.800). The award was made to the University of Maryland, Baltimore (UMB) to conduct research focusing on the use of deferoxamine as a potential treatment for traumatic brain injury. The project will run from...
This Cooperative Agreement award from the Air Force Research Laboratory (AFRL) under the Air Force Defense Research Sciences Program (CFDA 12.800) provides $202,407.00 to the University of Maryland, Baltimore (UMB) to develop an extended reality (XR) tool for assessing procedural readiness in U.S. Air Force medical forces. The project period runs from May 29, 2024 to May 29, 2025. As a major public research university, UMB has extensive expertise in biomedical and clinical research,...
This federal Cooperative Agreement award from the Department of the Air Force under the Air Force Defense Research Sciences Program (CFDA 12.800) provides $275,000.00 in funding to the University of Maryland, Baltimore (UMB) to conduct a "Study of the Delay of Oxygenation from the Lung to the Finger Using a Rapid and Automated Protocol." The award period is from July 10, 2024 to January 9, 2026. The Air Force Defense Research Sciences Program supports fundamental and applied...
The University of Maryland, College Park was awarded a $280,000 Project Grant from the Department of the Air Force Materiel Command Research Laboratory under the Air Force Defense Research Sciences Program (CFDA 12.800) to conduct research on multiscale characterization of collective astrocyte dynamics from August 1, 2021 through July 31, 2023. As part of the Air Force Defense Research Sciences Program, which aims to maintain Air Force technological superiority through basic and applied...
The University of Maryland, Baltimore received a $308,821 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund the development of a novel medical device called the TRANSESOPHAGEAL AORTIC BLOOD FLOW OCCLUDER to control non-compressible torso hemorrhage from January 15, 2022 to January 14, 2024. The device aims to transform trauma care for service members and the public through innovative...
The University of Maryland, College Park will receive $712,011 through a three-year Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420).
The grant will support modeling and cross-sectional analysis of movement quality for service members using osseointegrated prostheses. Through June 2026, the University will conduct research to transform health care and investigate medical solutions for the battlefield....
This Cooperative Agreement award from the Department of the Air Force Materiel Command Research Laboratory under the Air Force Defense Research Sciences Program (CFDA 12.800) was established to support the "Pharmacologic Induction of Tolerance for Hypoxia & Hypothermia (PHIT-HYHO)" project. The $563,960 award was made to the University of Maryland, Baltimore (UMB) on September 11, 2023, with a target completion date of June 11, 2025.
The award provides funding for UMB to conduct...